Ribosomal protein mRNAs are primary targets of regulation in RNase-L-induced senescence
暂无分享,去创建一个
[1] M. Gorospe,et al. Posttranscriptional gene regulation by RNA-binding proteins during oxidative stress: implications for cellular senescence , 2008, Biological chemistry.
[2] R. Silverman,et al. Hepatitis C virus RNA: dinucleotide frequencies and cleavage by RNase L. , 2007, Virus research.
[3] R. Silverman,et al. A scientific journey through the 2-5A/RNase L system. , 2007, Cytokine & growth factor reviews.
[4] J. Keene. RNA regulons: coordination of post-transcriptional events , 2007, Nature Reviews Genetics.
[5] David Bryant,et al. DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists , 2007, Nucleic Acids Res..
[6] R. Silverman,et al. Small-molecule activators of RNase L with broad-spectrum antiviral activity , 2007, Proceedings of the National Academy of Sciences.
[7] R. Silverman,et al. Role of 2-5A-dependent RNase-L in senescence and longevity , 2007, Oncogene.
[8] G. M. Wilson,et al. Post-transcriptional Regulation of RNase-L Expression Is Mediated by the 3′-Untranslated Region of Its mRNA* , 2007, Journal of Biological Chemistry.
[9] R. Silverman,et al. A Phylogenetically Conserved RNA Structure in the Poliovirus Open Reading Frame Inhibits the Antiviral Endoribonuclease RNase L , 2007, Journal of Virology.
[10] J. Derisi,et al. An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors , 2007, Proceedings of the National Academy of Sciences.
[11] Arul M. Chinnaiyan,et al. Selection and cloning of poly(rC)-binding protein 2 and Raf kinase inhibitor protein RNA activators of 2′,5′-oligoadenylate synthetase from prostate cancer cells , 2006, Nucleic acids research.
[12] I. Grummt,et al. Ribosome biogenesis and cell growth: mTOR coordinates transcription by all three classes of nuclear RNA polymerases , 2006, Oncogene.
[13] Roger J. Davis,et al. Control of cellular senescence by CPEB. , 2006, Genes & development.
[14] J. Derisi,et al. Identification of a Novel Gammaretrovirus in Prostate Tumors of Patients Homozygous for R462Q RNASEL Variant , 2006, PLoS pathogens.
[15] B. Williams,et al. A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase L. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[16] M. Bushell,et al. TOPs and their regulation. , 2006, Biochemical Society transactions.
[17] Geppino Falco,et al. Identification and Functional Outcome of mRNAs Associated with RNA-Binding Protein TIA-1 , 2005, Molecular and Cellular Biology.
[18] S. Peltz,et al. A newly discovered function for RNase L in regulating translation termination , 2005, Nature Structural &Molecular Biology.
[19] I. Kerr,et al. Synthesis, characterization and properties of ppp(A2'p)nApCp and related high-specific-activity 32P-labelled derivatives of ppp(A2'p)nA. , 2005, European journal of biochemistry.
[20] J. Campisi. Senescent Cells, Tumor Suppression, and Organismal Aging: Good Citizens, Bad Neighbors , 2005, Cell.
[21] K. Chandrasekaran,et al. RNase-L regulates the stability of mitochondrial DNA-encoded mRNAs in mouse embryo fibroblasts. , 2004, Biochemical and biophysical research communications.
[22] M. Yamashita,et al. Identification of 2′-Phosphodiesterase, Which Plays a Role in the 2-5A System Regulated by Interferon* , 2004, Journal of Biological Chemistry.
[23] P. Pandolfi,et al. The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis , 2004, Nature Medicine.
[24] J. Shay,et al. Hallmarks of senescence in carcinogenesis and cancer therapy , 2004, Oncogene.
[25] M. Gorospe,et al. Identification of a target RNA motif for RNA-binding protein HuR. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[26] R. Silverman,et al. Proteasome-mediated degradation of RNase L in response to phorbol-12-myristate-13-acetate (PMA) treatment of mouse L929 cells. , 2003, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[27] B. Williams,et al. RNase L Mediates Transient Control of the Interferon Response through Modulation of the Double-stranded RNA-dependent Protein Kinase PKR* , 2003, Journal of Biological Chemistry.
[28] K. Becker,et al. Analysis of microarray data using Z score transformation. , 2003, The Journal of molecular diagnostics : JMD.
[29] P. Walsh,et al. RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. , 2003, The Journal of urology.
[30] C. Schmitt. Senescence, apoptosis and therapy — cutting the lifelines of cancer , 2003, Nature Reviews Cancer.
[31] K. Klinger,et al. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1 , 2002, Nature Genetics.
[32] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[33] C. Bisbal,et al. The 2′-5′ Oligoadenylate/RNase L/RNase L Inhibitor Pathway Regulates Both MyoD mRNA Stability and Muscle Cell Differentiation , 2000, Molecular and Cellular Biology.
[34] Xiao-Ling Li,et al. RNase L Mediates the Antiviral Effect of Interferon through a Selective Reduction in Viral RNA during Encephalomyocarditis Virus Infection , 1998, Journal of Virology.
[35] R. Silverman,et al. Interferon action and apoptosis are defective in mice devoid of 2′,5′‐oligoadenylate‐dependent RNase L , 1997, The EMBO journal.
[36] C. Rivas,et al. Activation of the IFN-inducible enzyme RNase L causes apoptosis of animal cells. , 1997, Virology.
[37] M. Dalakas,et al. A Study of the Interferon Antiviral Mechanism: Apoptosis Activation by the 2–5A System , 1997, The Journal of experimental medicine.
[38] R. Silverman,et al. 2-5A-dependent RNase Molecules Dimerize during Activation by 2-5A (*) , 1995, The Journal of Biological Chemistry.
[39] J. Campisi,et al. Identification of a transcript that is down-regulated in senescent human fibroblasts. Cloning, sequence analysis, and regulation of the human L7 ribosomal protein gene. , 1993, The Journal of biological chemistry.
[40] R. Silverman,et al. A dominant negative mutant of 2‐5A‐dependent RNase suppresses antiproliferative and antiviral effects of interferon. , 1993, The EMBO journal.
[41] Robert H. Silverman,et al. Expression cloning of 2-5A-dependent RNAase: A uniquely regulated mediator of interferon action , 1993, Cell.
[42] R. Silverman,et al. Purification and analysis of murine 2-5A-dependent RNase. , 1988, The Journal of biological chemistry.
[43] A. De Benedetti,et al. Cleavage of nascent reovirus mRNA by localized activation of the 2'-5'-oligoadenylate-dependent endoribonuclease , 1984, Journal of virology.
[44] Silverman,et al. rRNA cleavage as an index of ppp(A2'p)nA activity in interferon-treated encephalomyocarditis virus-infected cells , 1983, Journal of virology.
[45] P. Lengyel,et al. Interferon action: RNA cleavage pattern of a (2'-5')oligoadenylate--dependent endonuclease. , 1981, Science.
[46] I. Kerr,et al. Ribosomal RNA cleavage, nuclease activation and 2-5A(ppp(A2'p)nA) in interferon-treated cells. , 1981, Nucleic acids research.
[47] T. Nilsen,et al. Analogs of (2'-5')oligo(A). Endonuclease activation and inhibition of protein synthesis in intact cells. , 1981, The Journal of biological chemistry.
[48] J. Skehel,et al. Interferon action—sequence specificity of the ppp(A2′p)nA-dependent ribonuclease , 1981, Nature.
[49] I. Kerr,et al. Natural occurrence of 2-5A in interferon-treated EMC virus-infected L cells , 1979, Nature.
[50] T. Nilsen,et al. Mechanism for discrimination between viral and host mRNA in interferon-treated cells. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[51] R. Silverman,et al. Tumour suppressor function of RNase L in a mouse model. , 2007, European journal of cancer.